Soriot commits to AstraZeneca as shares slideAstraZeneca (AZ) has tried to put a brave face on today’s news that its immunotherapy combination is unlikely to Share XSoriot commits to AstraZeneca as shares slidehttps://pharmaphorum.com/news/soriot-commits-astrazeneca-shares-slide/
Blow for AstraZeneca as cancer combination failsAfter several years of growing expectation, AstraZeneca’s long-awaited MYSTIC immune-oncology trial has failed to show benefit over standard Share XBlow for AstraZeneca as cancer combination failshttps://pharmaphorum.com/news/blow-astrazeneca-cancer-combination-fails/
